BACKGROUND: Exposure to the fungal allergen Alternaria alternata as well as ryegrass pollen has been implicated in severe asthma symptoms during thunderstorms. We have previously shown that Alternaria extract induces innate type 2 lung inflammation in mice. We hypothesized that the innate eosinophilic response to Alternaria extract may enhance lung inflammation induced by ryegrass. METHODS: Mice were sensitized to ryegrass allergen and administered a single challenge with A. alternata extract before or after final ryegrass challenges. Levels of eosinophils, neutrophils, Th2 cells, innate lymphoid cells (ILC2), interleukin (IL)-5 and IL-13 in bronchoalveolar lavage (BAL) as well as inflammation and mucus were assessed. RESULTS: Mice receiving ryegrass sensitization and challenge developed an eosinophilic lung response. A single challenge with Alternaria extract given 3 days before or 3 days after ryegrass challenges resulted in increased eosinophils, peribronchial inflammation and mucus production in the airways compared with ryegrass-only challenges. Type 2 ILC2 and Th2 cell recruitment to the airways was increased after Alternaria extract exposure in ryegrass-challenged mice. Innate immune challenges with Alternaria extract induced BAL eosinophilia, Th2 cell recruitment as well as ILC2 expansion and proliferation. CONCLUSIONS: A single exposure to Alternaria extract in ryegrass-sensitized and -challenged mice enhances the type 2 lung inflammatory response, including airway eosinophilia, peribronchial infiltrate, and mucus production, possibly through Th2 cell recruitment and ILC2 expansion. If translated to humans, exposure to both grass pollen and Alternaria may be a potential cause of thunderstorm-related asthma.
BACKGROUND: Exposure to the fungal allergen Alternaria alternata as well as ryegrass pollen has been implicated in severe asthma symptoms during thunderstorms. We have previously shown that Alternaria extract induces innate type 2 lung inflammation in mice. We hypothesized that the innate eosinophilic response to Alternaria extract may enhance lung inflammation induced by ryegrass. METHODS:Mice were sensitized to ryegrass allergen and administered a single challenge with A. alternata extract before or after final ryegrass challenges. Levels of eosinophils, neutrophils, Th2 cells, innate lymphoid cells (ILC2), interleukin (IL)-5 and IL-13 in bronchoalveolar lavage (BAL) as well as inflammation and mucus were assessed. RESULTS:Mice receiving ryegrass sensitization and challenge developed an eosinophilic lung response. A single challenge with Alternaria extract given 3 days before or 3 days after ryegrass challenges resulted in increased eosinophils, peribronchial inflammation and mucus production in the airways compared with ryegrass-only challenges. Type 2 ILC2 and Th2 cell recruitment to the airways was increased after Alternaria extract exposure in ryegrass-challenged mice. Innate immune challenges with Alternaria extract induced BAL eosinophilia, Th2 cell recruitment as well as ILC2 expansion and proliferation. CONCLUSIONS: A single exposure to Alternaria extract in ryegrass-sensitized and -challenged mice enhances the type 2 lung inflammatory response, including airway eosinophilia, peribronchial infiltrate, and mucus production, possibly through Th2 cell recruitment and ILC2 expansion. If translated to humans, exposure to both grass pollen and Alternaria may be a potential cause of thunderstorm-related asthma.
Authors: Jeffrey W Tyner; Edy Y Kim; Kyotaro Ide; Mark R Pelletier; William T Roswit; Jeffrey D Morton; John T Battaile; Anand C Patel; G Alexander Patterson; Mario Castro; Melanie S Spoor; Yingjian You; Steven L Brody; Michael J Holtzman Journal: J Clin Invest Date: 2006-02 Impact factor: 14.808
Authors: M Löhning; J L Grogan; A J Coyle; M Yazdanbakhsh; C Meisel; J C Gutierrez-Ramos; A Radbruch; T Kamradt Journal: J Immunol Date: 1999-04-01 Impact factor: 5.422
Authors: Edy Y Kim; John T Battaile; Anand C Patel; Yingjian You; Eugene Agapov; Mitchell H Grayson; Loralyn A Benoit; Derek E Byers; Yael Alevy; Jennifer Tucker; Suzanne Swanson; Rose Tidwell; Jeffrey W Tyner; Jeffrey D Morton; Mario Castro; Deepika Polineni; G Alexander Patterson; Reto A Schwendener; John D Allard; Gary Peltz; Michael J Holtzman Journal: Nat Med Date: 2008-05-18 Impact factor: 53.440
Authors: Attila Kiss; Martin Montes; Sarat Susarla; Elin A Jaensson; Scott M Drouin; Rick A Wetsel; Zhengbin Yao; Rachel Martin; Nabeel Hamzeh; Rebecca Adelagun; Sheila Amar; Farrah Kheradmand; David B Corry Journal: J Allergy Clin Immunol Date: 2007-06-04 Impact factor: 10.793
Authors: Thomas B Pulimood; Julie M Corden; Clare Bryden; Linda Sharples; Shuaib M Nasser Journal: J Allergy Clin Immunol Date: 2007-07-10 Impact factor: 10.793
Authors: Elizabeth A Oczypok; Pavle S Milutinovic; John F Alcorn; Anupriya Khare; Lauren T Crum; Michelle L Manni; Michael W Epperly; Adriane M Pawluk; Anuradha Ray; Tim D Oury Journal: J Allergy Clin Immunol Date: 2015-04-28 Impact factor: 10.793
Authors: Franz Puttur; Laura Denney; Lisa G Gregory; Juho Vuononvirta; Robert Oliver; Lewis J Entwistle; Simone A Walker; Mark B Headley; Ewan J McGhee; James E Pease; Matthew F Krummel; Leo M Carlin; Clare M Lloyd Journal: Sci Immunol Date: 2019-06-07
Authors: Maya R Karta; Peter S Rosenthal; Andrew Beppu; Christine Y Vuong; Marina Miller; Sudipta Das; Richard C Kurten; Taylor A Doherty; David H Broide Journal: J Allergy Clin Immunol Date: 2017-03-30 Impact factor: 10.793